97 related articles for article (PubMed ID: 19454838)
1. Analysis of inhaled corticosteroid selection in patients with bronchial asthma using a questionnaire survey--effects of age, gender, and disease severity.
Ota K; Hasegawa T; Koya T; Sakagami T; Sekikawa T; Toyabe S; Akazawa K; Arakawa M; Gejyo F; Suzuki E
Allergol Int; 2009 Sep; 58(3):365-71. PubMed ID: 19454838
[TBL] [Abstract][Full Text] [Related]
2. Influence of dentures on residual inhaled corticosteroids in the mouths of elderly asthma patients.
Ohbayashi H; Adachi M
Respir Investig; 2012 Jun; 50(2):54-61. PubMed ID: 22749251
[TBL] [Abstract][Full Text] [Related]
3. [An evaluation of the acceptance of budesonide turbuhaler by older Japanese patients with bronchial asthma when changed from fluticasone propionate (FP) or beclomethasone dipropionate (BDP)].
Ohbayashi H; Yamase H
Arerugi; 2003 Jan; 52(1):31-8. PubMed ID: 12598720
[TBL] [Abstract][Full Text] [Related]
4. [A multicenter, open-label, randomized comparison of suppressive effects on asthmatic inflammation of lower airways and improved effects on health-related QOL between HFA-BDP and fluticasone propionate].
Ohbayashi H; Adachi M; Ichinose M; Ohta K; Kokubu F; Sano Y; Tamura G; Tohda Y; Hirata K; Yasuba H
Arerugi; 2007 Jun; 56(6):577-86. PubMed ID: 17615501
[TBL] [Abstract][Full Text] [Related]
5. [The small airway inflammation of asthmatic patients who have used dry powder type inhaled steroid for moderate-long term evaluated by induced sputum and the efficacy of HFA-BDP (QVAR) inhalation].
Ohbayashi H
Arerugi; 2005 Jan; 54(1):24-35. PubMed ID: 15841673
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
7. Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone.
Colice G; Martin RJ; Israel E; Roche N; Barnes N; Burden A; Polos P; Dorinsky P; Hillyer EV; Lee AJ; Chisholm A; von Ziegenweidt J; Barion F; Price D
J Allergy Clin Immunol; 2013 Jul; 132(1):45-54. PubMed ID: 23591272
[TBL] [Abstract][Full Text] [Related]
8. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
FitzGerald JM; Boulet LP; Follows RM
Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
[TBL] [Abstract][Full Text] [Related]
9. [Inhaled corticosteroids: first-line therapy in asthma].
Hajiro T; Ishihara K
Nihon Rinsho; 2001 Oct; 59(10):1967-72. PubMed ID: 11676140
[TBL] [Abstract][Full Text] [Related]
10. Improved safety with equivalent asthma control in adults with chronic severe asthma on high-dose fluticasone propionate.
Berend N; Kellett B; Kent N; Sly PD;
Respirology; 2001 Sep; 6(3):237-46. PubMed ID: 11555383
[TBL] [Abstract][Full Text] [Related]
11. Real-world effects of two inhaled corticosteroid/long-acting β₂-agonist combinations in the treatment of asthma.
Yatera K; Yamasaki K; Nishida C; Noguchi S; Oda K; Akata K; Nagata S; Kawanami Y; Kawanami T; Ishimoto H; Mukae H
J Asthma; 2014 Sep; 51(7):762-8. PubMed ID: 24654703
[TBL] [Abstract][Full Text] [Related]
12. The usefulness of inspiratory flow rate during inhalation corticosteroid therapy in asthma.
Banno M; Ibata H; Niimi T; Sato S; Matsushita R
Respiration; 2009; 78(4):387-92. PubMed ID: 19451702
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group.
Pauwels RA; Yernault JC; Demedts MG; Geusens P
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):827-32. PubMed ID: 9517598
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function.
Nielsen LP; Dahl R
Am J Respir Crit Care Med; 2000 Dec; 162(6):2053-7. PubMed ID: 11112113
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].
Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
Pol Merkur Lekarski; 2004; 17 Suppl 2():5-10. PubMed ID: 15688663
[TBL] [Abstract][Full Text] [Related]
16. One-year evaluation of the preventative effect of hydrofluoroalkane-beclomethasone dipropionate on eosinophilic inflammation of asthmatic peripheral airways.
Ohbayashi H
Respiration; 2007; 74(2):146-53. PubMed ID: 16804291
[TBL] [Abstract][Full Text] [Related]
17. Real life clinical study design supporting the effectiveness of extra-fine inhaled beclomethasone/formoterol at the level of small airways of asthmatics.
Popov TA; Petrova D; Kralimarkova TZ; Ivanov Y; Popova T; Peneva M; Odzhakova T; Ilieva Y; Yakovliev P; Lazarova T; Georgiev O; Hodzhev V; Hodzheva E; Staevska MT; Dimitrov VD
Pulm Pharmacol Ther; 2013 Dec; 26(6):624-9. PubMed ID: 23769863
[TBL] [Abstract][Full Text] [Related]
18. Improvement in health-related quality of life with fluticasone propionate compared with budesonide or beclomethasone dipropionate in adults with severe asthma.
Rutherford C; Mills R; Gibson PG; Price MJ
Respirology; 2003 Sep; 8(3):371-5. PubMed ID: 12911833
[TBL] [Abstract][Full Text] [Related]
19. Hydrofluoroalkane-beclomethasone dipropionate effectively improves airway eosinophilic inflammation including the distal airways of patients with mild to moderate persistent asthma as compared with fluticasone propionate in a randomized open double-cross study.
Ohbayashi H; Adachi M
Allergol Int; 2008 Sep; 57(3):231-9. PubMed ID: 18493166
[TBL] [Abstract][Full Text] [Related]
20. Potency ratio fluticasone propionate (Flixotide Diskus)/budesonide (Pulmicort Turbuhaler).
Ställberg B; Pilman E; Skoogh BE; Hermansson BA
Respir Med; 2007 Mar; 101(3):610-5. PubMed ID: 16889952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
